Plastic Surgery - The new Botox (R)?

There may be a “new” Botox(R) on the market soon.

With its popularity unquestioned, Botox(R) may have a new French challenger. The drug is called Azzalure and it was developed by French drug maker Ipsen.

A few weeks ago, it was approved in Britain for use on the glabellar crease – those deep frown lines between your eyebrows. For years the drug has been sold as Dysport and used to treat spasms.

Like Botox(R), it is produced by the bacterium Clostridium Botulinum. Azzalure has been approved by health authorities in 15 European countries.

In the U.S., Ipsen has granted Medici Pharmaceutical the rights to market the drug for cosmetic use under the name Reloxin.

The FDA is reviewing their application. Their decision was due April 13^th – keep your fingers crossed.

Competition is good – it leads to lower prices.

Of course, for more and more current information about Botox, Azzalure or any filler, contact Dr. Brueck at 239-939-5233. For more information about Dr. Brueck, his practice and his specialties, stop by his web site at Beauty-by-Brueck.com.